Financials
- Financial year
- 2025
- Total assets
- €976,468
- Loss
- -€634,047
- Solvency
- 89.3%
Arthro ID
ActiveSummary
The computed 12-month bankruptcy probability of Arthro ID is 1.6% (moderate). The annual accounts of Arthro ID for financial year 2025 show a net loss of 65% of total assets. The 2025 annual accounts show equity of €871,932 and a net result of -€634,047. Its solvency ranks better than 83% of 613 sector peers (NACE 72, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Other research and development on natural sciences
NACE 72109
1 site
Size
€976,468total assets 2025
- Equity
- €871,932
- Loss
- -€634,047
Turnover not published (micro format)
Structure
- Board
- 5 members
2025 accounts 32 days early
Why 56raises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial year2 changes of registered office in 24 monthsLoss of €634,047 (financial year 2025)lowers riskSector: Scientific research and development (NACE 72)Liquidity: current ratio 8.77, cash €859,186Show the evidence
Checked score
Score 2025
56
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 61% of its sector peers (NACE 72, micro)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency
100
equity 89.3% of total assets
Liquidity
100
short-term debt 10.7% · cash 88.0%
Profitability
0
return on assets -64.9%
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
08-2025: 1.1%lowest value
09-2025: 1.2%▲ +0.1 percentage points vs 08-2025
10-2025: 1.2%● unchanged vs 09-2025
11-2025: 1.3%▲ +0.1 percentage points vs 10-2025
12-2025: 1.4%▲ +0.1 percentage points vs 11-2025
01-2026: 1.4%● unchanged vs 12-2025
02-2026: 1.5%▲ +0.1 percentage points vs 01-2026
03-2026: 1.5%● unchanged vs 02-2026
04-2026: 1.5%● unchanged vs 03-2026
05-2026: 1.5%● unchanged vs 04-2026
06-2026: 4.1%▲ +2.6 percentage points vs 05-2026highest value
07-2026: 1.6%▼ -2.5 percentage points vs 06-2026
08-2026: 1.6%● unchanged vs 07-2026
09-2026: 1.6%● unchanged vs 08-2026
10-2026: 1.6%● unchanged vs 09-2026
Credit of up to €45,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 8.77, above the usual 1.5; short-term debt: 10.7% and cash: 88% of total assets), and 10.7% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 83% on solvency, 91% on liquidity and 10% on profitability.
The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
32 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- Registered officeRegistered-office move
- Capital & shares · Amendment of…Capital contribution · Financial instrument…
Key points
By topic
Board & ownership
- Board
- 5 members
- LUYCKX Thomas Pieter Johannes FredericusDirector
- RYCKAERT Alexander Elza GerardDirector
- Caset PeterDirector
- POLLET Sofie VeerleDirector
- XCD B.V.Director
Network & group
- Connected companies
- 9
Timeline
- Events
- 6
- Since
- 2024
- 22-07-2025Capital & shares · Amendment of the…
- 22-07-2025Resignations: LUYCKX Thomas (director) and RYCKAERT Alexander…
- 09-07-2024Incorporation
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Other research and development on natural sciencesNACE 72109
- Founded
- 05-07-2024
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 31
- Purpose
- “Het verwerven van participaties in eender welke vorm alsmede het betrokken zijn bij wijze…” (deed in Dutch)
- Statutory auditor
- No statutory auditor
Key facts about Arthro ID
- What is the company number of Arthro ID?
- 1011.212.429. In Belgium the VAT number is the company number with BE in front: BE 1011.212.429.
- Where is Arthro ID based?
- The registered office is at Borsbeeksebrug 22, 2600 Antwerpen.Company details
- What does Arthro ID do?
- According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
- What is the legal form of Arthro ID?
- Private limited company (BV).
- When was Arthro ID founded?
- On 05-07-2024.
- Is Arthro ID still active?
- Yes, Arthro ID is an active enterprise in the KBO register.
- What is the turnover of Arthro ID?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Arthro ID profitable?
- In financial year 2025, Arthro ID made a loss of €634,047.
- Where can I find the annual accounts of Arthro ID?
- Arthro ID filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Companies related to Arthro ID
Comparable companies
- INCIZEOttignies-Louvain-la-Neuve
- CANNOVEXDiepenbeek
- E-VENTIONOttignies-Louvain-la-Neuve
- Médecine générale VERHAEREN -GOFFARDTheux
- MARBLE PHARMA CONSULTLasne
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.